USPTO serial 97231267
CopyMark Law Group can help you respond to USPTO correspondence, keep a registration alive, or watch new filings against your mark.
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Deadline: 27 Oct 2026
The USPTO requires us to appoint a U.S.-licensed attorney for you, and has temporarily deferred the search for conflicting marks while your application undergoes administrative review.
New Gene (Hangzhou) Bioengineering Co., Ltd.
Hangzhou, Zhejiang,, CN
| Class | Description | Status | First use |
|---|---|---|---|
| 010 | Apparatus for magnet therapy; Blood testing apparatus; Body composition analyzers for medical purposes; Body composition monitors; Electrotherapy devices for providing transcutaneous electrical nerve stimulation, infrared heat and compression; Inhalers for medical use; Needles for medical purposes; Surgical apparatus and instruments for medical, dental or veterinary use; Syringes for medical purposes; Urological imaging systems | ACTIVE | Dec 1, 2021 |
| Date | Code | Event |
|---|---|---|
| Aug 27, 2026 | DOCK | ASSIGNED TO EXAMINER |
| Jul 27, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Jul 27, 2026 | GNRT | NON-FINAL ACTION E-MAILED |
| Jul 27, 2026 | CNRT | NON-FINAL ACTION WRITTEN |
| Jul 20, 2026 | DOCK | ASSIGNED TO EXAMINER |
| Jul 7, 2023 | WOAG | WITHDRAWAL OF ATTORNEY GRANTED |
| Jul 7, 2023 | WOAR | TEAS WITHDRAWAL OF ATTORNEY RECEIVED |
| Jan 26, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Jan 25, 2022 | NWAP | NEW APPLICATION ENTERED |